| Infectious complications of induction therapies in kidney transplantation A Bayraktar, Y Catma, A Akyildiz, E Demir, H Bakkaloglu, AR Ucar, ... Annals of transplantation 24, 412, 2019 | 26 | 2019 |
| Co-deposition of IgM and C3 may indicate unfavorable renal outcomes in adult patients with primary focal segmental glomerulosclerosis S Mirioglu, Y Caliskan, Y Ozluk, AB Dirim, Z Istemihan, A Akyildiz, ... Kidney and Blood Pressure Research 44 (5), 961-972, 2019 | 17 | 2019 |
| MP805 EFFECTS OF PROTON PUMP INHIBITORS ON KIDNEY TRANSPLANT RECIPIENTS O Uludag, S Mirioglu, A Dirim, O Akardere, A Akyildiz, M Sever, ... Nephrology Dialysis Transplantation 32 (suppl_3), iii730-iii730, 2017 | 5 | 2017 |
| A meta-analysis of the association between adjuvant chemoradiotherapy and disease-free survival in gastric cancer according to the histology HC Yildirim, DC Guven, A Akyildiz, S Yalcin, O Dizdar Irish Journal of Medical Science (1971-) 192 (6), 2631-2634, 2023 | 2 | 2023 |
| The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey A Akyildiz, DC Guven, AA Ozluk, R Ismayilov, E Mutlu, OU Unal, I Yildiz, ... Medicine 102 (45), e35950, 2023 | 2 | 2023 |
| Efficacy of Capecitabine and Temozolomide regimen in neuroendocrine tumors: data from the Turkish oncology group Ç Ünal, A Azizy, S Karabulut, D Taştekin, A Akyıldız, S Yaşar, Ş Yalçın, ... The oncologist 28 (10), 875-884, 2023 | 2 | 2023 |
| Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort A Akyildiz, DC Guven, HC Yildirim, R Ismayilov, F Yilmaz, OD Tatar, ... Medicine 102 (18), e33677, 2023 | 2 | 2023 |
| Emerging treatment strategies in hepatobiliary cancer DC Guven, HC Yildirim, E Chalabiyev, F Kus, F Yilmaz, S Yasar, ... Expert Review of Anticancer Therapy 23 (3), 243-256, 2023 | 2 | 2023 |
| Prognostic factors associated with locally advanced gastric cancer in patients treated with adjuvant chemotherapy H YILDIRIM, D Güven, E Chalabiyev, H Taban, F YILMAZ, S YAŞAR, ... Journal of Oncological Science 8 (3), 2022 | 2 | 2022 |
| KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer F Kus, DC Guven, HC Yildirim, E Chalabiyev, A Akyildiz, OD Tatar, ... Biomarkers in Medicine 17 (7), 379-389, 2023 | 1 | 2023 |
| Effect of rituximab in patients with relapsed or refractory primary membranous nephropathy A Akyildiz, Ö ULUDAĞ, Ş MİRİOĞLU, AR Ucar, E Demir, YK ÇALIŞKAN, ... | 1 | 2020 |
| Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish … A Akyildiz, M Gultekin, E Yigit, E Demir, R Ismayilov, M Ahmed, ... International Journal of Gynecologic Cancer, ijgc-2024-005419, 2024 | | 2024 |
| Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine TK Sahin, A Akyildiz, OT Dogan, G Kavgaci, DC Guven, S Aksoy Pharmaceuticals 17 (7), 824, 2024 | | 2024 |
| Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology … A Akyildiz, DC Guven, B Koksal, BB Karaoglan, D Kivrak, R Ismayilov, ... European Archives of Oto-Rhino-Laryngology, 1-9, 2024 | | 2024 |
| Sirolimus experience in adult patients with vascular malformations A Akyildiz, R Ismayilov, DC Guven, HC Yildirim, OD Tatar, F Kus, ... Vascular, 17085381241241853, 2024 | | 2024 |
| Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab HC Yildirim, H Anik, DA Ozdemir, R Ismayilov, A Akyildiz, K Cayiroz, ... Biomolecules and Biomedicine, 2024 | | 2024 |
| Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for … A Akyildiz, R Ismayilov, N Rustamova, M Tokatli, I Koc, S Akin, H Kiratli, ... Annals of Hematology 103 (3), 905-915, 2024 | | 2024 |
| 68P Real-world clinical and treatment-related outcomes in specific subgroups of patients with BRAF-positive metastatic melanoma treated with dabrafenib-trametinib: Turkish … EC Yildirim, HS Semiz, A Akyildiz, S Yaslikaya, PC Sanci, M Guliyev, ... ESMO Open 9, 2024 | | 2024 |
| 9P The efficacy of HIF-1 alpha expression in the response to first-line standard chemotherapy and bevacizumab treatment in patients diagnosed with metastatic cervical cancer HC Yildirim, H Anık, DA Ozdemir, R Ismayilov, A Akyildiz, K Cayiroz, ... ESMO Open 9, 2024 | | 2024 |
| A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer HC Yildirim, R Ismayilov, A Akyildiz, DC Guven, N Abdurrahimli, O Dizdar, ... Anti-cancer drugs, 2023 | | 2023 |
